Trial intelligence / Profile preview

Convalescent Plasma in Severe COVID-19

NCT04415086Phase 2Completed

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Jun 2020
Primary completion
Feb 2022
Modality
Biologic
Countries
1
01

Overview

A Phase 2 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Jun 2020; status: completed.

02

Drugs

convalescent plasma (Heinrich-Heine University, Duesseldorf)
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04415086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04415086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call